Previous studies detected MDM2 expression in tumor tissue and normal lung tissue in patients with NSCLC and found that MDM2 expression was related to tumor differentiation degree, clinical stage and lymph node metastasis. This evidence concerns the gene MDM2 and metastatic malignant neoplasm in the lymph nodes.